The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTatton Asset Management Regulatory News (TAM)

Share Price Information for Tatton Asset Management (TAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 618.00
Bid: 592.00
Ask: 618.00
Change: 32.00 (5.46%)
Spread: 26.00 (4.392%)
Open: 586.00
High: 620.00
Low: 586.00
Prev. Close: 586.00
TAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealing

21 Jun 2007 07:00

Titanium Asset Management Corp 21 June 2007 Not for release, publication or distribution in, or into, the United States, Canada, Australia, Japan, the Republic of Ireland or South Africa Press Release June 21, 2007 Titanium Asset Management Corp. ('Titanium' or the 'Company') Successful completion of US$120,000,000 financing and first day of dealings Titanium Asset Management Corp., established to acquire companies engaged in the asset management industry, announces the admission of its common shares and warrants to trading on the AIM Market ('AIM') of the London Stock Exchange plc. Seymour Pierce Limited is acting as both Nominated Adviser and Broker to the Company. Sunrise Securities Corp. acted as Global Co-ordinator, Sole Bookrunner, Financial Adviser and Placing Agent. The trading symbols for the common shares and warrants are TAM.L and TAMW.L respectively. Titanium intends to acquire a number of specialists as well as multiproduct asset management firms with complementary investment strategies and strong investment performance which will then be managed as an integrated business. Titanium has already signed three Letters of Intent to acquire asset management businesses with combined assets under management of an estimated combined US$3.5bn. The acquisition strategy will initially focus on the US market, but will then be rolled out globally. Titanium has placed 20,000,000 units at US$6.00, each unit comprising one share and one warrant, raising US$120,000,000 before expenses. Clal Finance Ltd, an investment bank quoted on the Tel Aviv Stock Exchange, has acquired 10,100,000 units at the placing. A number of other major international institutional investors participated in the placing. Titanium has assembled a strong management team with extensive experience in the global asset management industry, led by Mr. John Kuzan as Chairman, Mr. John Sauickie as CEO and Mr. Nigel Wightman, Executive Director. Commentating on the placing Mr. Wightman, Executive Director, said: 'We are delighted to have the support of a strong shareholder group to pursue our business strategy. We believe that the global asset management industry will continue to grow significantly and we hope to acquire both specialist and multiproduct firms where we are able to expand the scale and scope of distribution to improve rates of asset accumulation.' Subject to compliance with applicable laws, stabilisation may be undertaken in relation to the shares during the period ending 20 July 2007 if the market price per share is less than $5.50. However stabilisation may cease at any time and there is no assurance that stabilisation will be undertaken. The manner in which the stabilisation will be undertaken is set out in the Company's admission document dated 18 June 2007. The common shares and warrants in the Company have not been registered under the U.S. Securities Act of 1933, as amended. The common shares and warrants may not be offered or sold within the U.S. or to U.S. persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Hedging transactions involving the Shares or Warrants may not be conducted unless in compliance with the Securities Act. For further information: Titanium Asset Management Corp Nigel Wightman, Executive Director Tel: +44 (0) 20 7822 1881 Seymour Pierce Limited Jonathan Wright, Director Tel: +44 (0) 20 7107 8000 Sunrise Securities Corp. Tel: (212) 421-1616 Dr. Amnon Mandelbaum, Senior Managing Director Penrose Financial Gay Collins Tel: +44 (0) 20 7786 4882 Mob: 07798626282 Julie Allison Tel: +44 (0) 20 7786 4872 Notes to editors: Clal Finance is Israel's largest publicly traded financial institution outside the banking system, providing a broad array of financial services, ranging from portfolio management to brokerage and underwriting services. It owns and operates mutual funds, an in-house hedge fund, and offers individually tailored structured products to clients. Clal Finance is owned 77% by Clal Insurance Enterprises Holdings and 23% by the public. Clal Insurance Enterprises Holdings is itself a publicly traded company in which IDB Development Corporation, one of Israel's largest holding companies, holds a 51% stake and Hapoalim Bank a 14% stake. THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION OR DISTRIBUTION INTO THE UNITED STATES. THE MATERIAL SET FORTH HEREIN IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT INTENDED, AND SHOULD NOT BE CONSTRUED, AS AN OFFER OF SECURITIES FOR SALE INTO THE UNITED STATES OR ANY OTHER JURISDICTION. THE SECURITIES OF THE COMPANY DESCRIBED HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE 'SECURITIES ACT'), OR THE LAWS OF ANY STATE, AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE LAWS. THERE IS NO INTENTION TO REGISTER ANY PORTION OF THE PLACING IN THE UNITED STATES OR TO CONDUCT A PUBLIC OFFERING OF SECURITIES IN THE UNITED STATES.
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update and Notice of Final Results
5th Apr 20241:27 pmRNSDirector/PDMR Shareholding
28th Mar 20243:37 pmRNSDirector/PDMR Shareholding
21st Mar 20244:56 pmRNSDirector/PDMR Shareholding
12th Mar 20244:56 pmRNSStandard form for notification of major holdings
28th Feb 20245:37 pmRNSDirector/PDMR Shareholding
25th Jan 20243:48 pmRNSHolding(s) in Company
15th Jan 20243:30 pmRNSDirector/PDMR Shareholding
29th Dec 202312:29 pmRNSStandard form for notification of major holdings
18th Dec 20231:12 pmRNSStandard form for notification of major holdings
16th Nov 20237:00 amRNSUnaudited Interim Results
8th Nov 20237:00 amRNSHalf Year Results Presentations
19th Oct 20237:00 amRNSTrading Update and Notice of Results
13th Sep 202312:01 pmRNSTR-1
5th Sep 20233:17 pmRNSIssue of Shares
4th Sep 20231:20 pmRNSDirector/PDMR Shareholding
31st Aug 202310:28 amRNSExercise of options and PDMR dealing
9th Aug 20233:10 pmRNSResult of AGM
13th Jul 20234:10 pmRNSDirector/PDMR Shareholding
30th Jun 20235:19 pmRNSDirector/PDMR Shareholding
29th Jun 20235:09 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSNotice of AGM
14th Jun 20235:35 pmRNSTR-1
14th Jun 20234:25 pmRNSTR-1
13th Jun 20237:00 amRNSAudited Final Results
18th May 20237:00 amRNSFinal Results Presentations
4th May 20232:56 pmRNSHolding(s) in Company
3rd May 20239:17 amRNSPDMR Shareholding
18th Apr 20237:00 amRNSTrading Update and Notice of Final Results
21st Mar 20233:05 pmRNSHolding(s) in Company
1st Feb 20235:12 pmRNSHolding(s) in Company
20th Dec 20229:31 amRNSIssue of Shares
14th Dec 20221:08 pmRNSIssue of shares
23rd Nov 20227:00 amRNSIssue of shares
22nd Nov 20227:00 amRNSInterim results for the six-months to 30 Sept 2022
2nd Nov 20227:00 amRNSHalf-Year Results Presentations
18th Oct 20227:00 amRNSTrading Update and Notice of Results
26th Sep 202212:43 pmRNSIssue of Shares
7th Sep 20225:25 pmRNSIssue of shares
30th Aug 20227:28 amRNSPDMR Shareholding
18th Aug 20225:07 pmRNSHolding(s) in Company
17th Aug 20227:50 amRNSHolding(s) in Company
15th Aug 20227:00 amRNSCompletion of Acquisition, Issue of Shares and TVR
27th Jul 202211:28 amRNSResult of AGM
27th Jun 20227:00 amRNSNotice of AGM
20th Jun 20222:36 pmRNSOption Exercise and PDMR Dealings
15th Jun 20227:00 amRNSAudited Final Results - year ended 31 March 2022
31st May 20227:00 amRNSFinal Results Presentations
4th May 20227:00 amRNSPDMR Shareholding
28th Apr 202212:03 pmRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.